Diary Prequel Package — page 417

dy Ebola. People like Eric Green (NHGRI) disagree with me. I do not like or trust Eric as I believe that he resents me because he is intimidated by my accomplishments and notoriety. That is life. Also, the "elephant" in the room with the distribution of the AIDS money by OAR that no one wants to address is that NIDA is spending about $180 million on drug abuse issues when ~7% of USA cases are drug abuse and one can stop this with needle exchange. I feel they should get some money, but not that much when we do not have enough to conduct vaccine trials that could end the pandemic. Dec. 9, 2014 - Participated in the The Atlantic STEM summit at GW (cold and rainy day). Was interviewed by my old media friend Frank Sesno (formerly of CNN and NPR) who now heads the Public Affairs Institute at GW. Nice crowd, good questions, well-received. Dec. 10, 2014 - Gave talk at Italian Embassy on Ebola followed by being interviewed by Ted Koppel, my old buddy from "Night Line". Great interview. Ted praised me as a national hero. Today "Time" magazine named the "Ebola HCWs" as "Persons of the Year" great choice as they put themselves in serious harm's way. Dec. 11, 2014 - Will receive new patient at SCSU. nurse ftrom San Francisco volunteering in Sierra Leone with NGO got needle stick injury taking care of documented critically ill Ebola patient. High risk exposure. Flying in today. Woods_MedEvacFile. docx Saw this evening. Donned and doffed just droplet precautions since she is asymptomatic. Showered out anyway. is comfortable, received VSV post-exposure prophylaxis. Presented Ebola talk to ACD (Advisory Committee to the Director) of NIH. Great reception. Moncef Slaoui (GSK) is member of ACD and he was cordial and agreed completely about the need for an RCT for Ebola Vaccine. Ian Lipkin (also on ACD) strongly felt against it and wants open access. Am surprised at Ian since I thought he was more of a scientist. Note that he is not a clinical investigator; he is a good friend of mine. He is moved by all the suffering and death. The Swiss Phase 1 trial on VSV has been put on hold due to 4 cases out of 39 of "arthritis" (mild). We have seen arthralgias and myalgias (expected) in our VSV trial at the Clinical Center, but not arthritis even at 10x the dose of the Swiss study. Puzzling.... Gave entrance interview with producer from CBS who wants to do a profile on me. Dec. 12, 2014 - Went to White House today for meeting 1:45 PM to 3:00 PM in the Roosevelt Room. Crystal clear, crisp and cold December day. Meeting was to review the situation with the Ebola-ready hospitals and Assessment Hospitals in the USA and to discuss the shifting of resources from Liberia (low infection rate now) to Sierra Leone (rising infection rate). Present at the meeting were: POTUS, VP Biden, Lisa Monaco,